Fortress Biotech Inc reports results for the quarter ended in December - Earnings Summary

Fortress Biotech

28/03/2024 23:25

* Fortress Biotech Inc  FBIO.OQ  reported a quarterly
adjusted
loss of 53 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-4.46.  The mean expectation of five analysts
for the quarter was for a loss of $1.97 per share. Wall Street
expected results to range from $-2.61 to $-1.49 per share.
    * Revenue rose 21.6% to $19.95 million from a year ago;
analysts
expected $14.89 million. 
    * Fortress Biotech Inc's reported EPS for the quarter was a
loss
of $1.28​.
    * The company reported a quarterly loss of $9.28 million.
    * Fortress Biotech Inc shares had fallen by 27.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 20.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Fortress Biotech
Inc is $10.00 
This summary was machine generated from LSEG data March 28 at
11:25 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.97          -0.53          Beat
 Sep. 30 2023      -3.21          -0.94          Beat
 Jun. 30 2023      -3.41          -3.60          Missed
 Mar. 31 2023      -3.00          -3.15          Missed